m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Gene expression can be posttranscriptionally regulated by a complex network of proteins. N1-methyladenosine (m1A) is a newly validated RNA modification. However, little is known about both its influence and biogenesis in tumor development. METHODS: This study analyzed TCGA data of patients with five kinds of gastrointestinal (GI) cancers. Using data from cBioPortal, molecular features of the nine known m1A-related enzymes in GI cancers were investigated. Using a variety of bioinformatics approach, the impact of m1A regulators on its downstream signaling pathway was studied. To further confirm this regulation, the effect of m1A writer ALKBH3 knockdown was studied using RNA-seq data from published database. RESULTS: Dysregulation and multiple types of genetic alteration of putative m1A-related enzymes in tumor samples were observed. The ErbB and mTOR pathways with ErbB2, mTOR, and AKT1S1 hub genes were identified as being regulated by m1A-related enzymes. The expression of both ErbB2 and AKT1S1 was decreased after m1A writer ALKBH3 knockdown. Furthermore, Gene Ontology analysis revealed that m1A downstream genes were associated with cell proliferation, and the results showed that m1A genes are reliably linked to mTOR. CONCLUSION: This study demonstrated for the first time the dysregulation of m1A regulators in GI cancer and its signaling pathways and will contribute to the understanding of RNA modification in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
STRING v10: protein–protein interaction networks, integrated over the tree of life
Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1003 · Cited by 10,436
Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. L., Beroukhim, R., & Getz, G. (2011) · Genome Biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,550 · cited 4×
“After filtering incomplete clinical data fromTCGAbased onGISTIC annotation [35], total GI cancer patients with different cluster of regulator genes were categorized as altered and unaltered groups.”
BackgroundMethodInfluentialDynamic RNA Modifications in Gene Expression Regulation
Roundtree, I. A., Evans, M. E., Pan, T., & He, C. (2017) · Cell · doi:10.1016/j.cell.2017.05.045 · Cited by 3,399 · cited 3×
“The unique physicochemical properties of m1A play a crucial role in maintaining the correct structure and function of these noncoding RNAs (ncRNAs) [16].”
BackgroundInfluentialDNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437 · cited 1×
“Aberrant changes in DNAmethylations have also been reported in GI cancers [28].”
BackgroundGene expression regulation mediated through reversible m6A RNA methylation
Fu, Y., Dominissini, D., Rechavi, G., & He, C. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3724 · Cited by 1,935
MODOMICS: a database of RNA modification pathways. 2017 update
Boccaletto, P., Machnicka, M. A., Purta, E., Piątkowski, P., Bagiński, B., Wirecki, T. K., de Crécy-Lagard, V., Ross, R., Limbach, P. A., Kotter, A., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1030 · Cited by 1,782
GOSemSim: an R package for measuring semantic similarity among GO terms and gene products
Yu, G., Li, F., Qin, Y., Bo, X., Wu, Y., & Wang, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq064 · Cited by 1,388
Self-citationA new method to measure the semantic similarity of GO terms
Wang, J. Z., Du, Z., Payattakool, R., Yu, P. S., & Chen, C.-F. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm087 · Cited by 1,377 · cited 1×
“This takes the GO topological structure into account [60].”
BackgroundThe dynamic N1-methyladenosine methylome in eukaryotic messenger RNA
Dominissini, D., Nachtergaele, S., Moshitch-Moshkovitz, S., Peer, E., Kol, N., Ben-Haim, M. S., Dai, Q., Di Segni, A., Salmon-Divon, M., Clark, W. C., et al. (2016) · Nature · doi:10.1038/nature16998 · Cited by 1,021 · cited 1×
“Meanwhile, m1A is also found to have a strong enrichment effect on translation in 50UTR [14].”
BackgroundMODOMICS: a database of RNA modification pathways—2013 update
Machnicka, M. A., Milanowska, K., Osman Oglou, O., Purta, E., Kurkowska, M., Olchowik, A., Januszewski, W., Kalinowski, S., Dunin-Horkawicz, S., Rother, K. M., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1007 · Cited by 1,013 · cited 2×
“Adding a methyl group at the N1 position of adenosine forms m1A [11,12].”
BackgroundDysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972 · cited 1×
“AKT1S1, mTOR, Raptor, and DEPTOR have been previously demonstrated as part of mTORC1 complex [50].”
BackgroundThe role of m6A RNA methylation in cancer
Sun, T., Wu, R., & Ming, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108613 · Cited by 963 · cited 1×
“Studies have revealed that m6A RNA methylation provides an effective direction for early diagnosis and treatment of pancreatic cancer and hepatocellular carcinoma [30].”
BackgroundRegulation of histone methylation by demethylimination and demethylation
Klose, R. J., & Zhang, Y. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2143 · Cited by 887
Liu, J., Eckert, M. A., Harada, B. T., Liu, S.-M., Lu, Z., Yu, K., Tienda, S. M., Chryplewicz, A., Zhu, A. C., Yang, Y., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0174-4 · Cited by 778
Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage
Trewick, S. C., Henshaw, T. F., Hausinger, R. P., Lindahl, T., & Sedgwick, B. (2002) · Nature · doi:10.1038/nature00908 · Cited by 762
Transcriptome-wide mapping reveals reversible and dynamic N1-methyladenosine methylome
Li, X., Xiong, X., Wang, K., Wang, L., Shu, X., Ma, S., & Yi, C. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2040 · Cited by 683
Self-citationThe m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution
Safra, M., Sas-Chen, A., Nir, R., Winkler, R., Nachshon, A., Bar-Yaacov, D., Erlacher, M., Rossmanith, W., Stern-Ginossar, N., & Schwartz, S. (2017) · Nature · doi:10.1038/nature24456 · Cited by 646
Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA
Aas, P. A., Otterlei, M., Falnes, P. Ø., Vågbø, C. B., Skorpen, F., Akbari, M., Sundheim, O., Bjørås, M., Slupphaug, G., Seeberg, E., et al. (2003) · Nature · doi:10.1038/nature01363 · Cited by 638
Schwartz, S., Agarwala, S. D., Mumbach, M. R., Jovanovic, M., Mertins, P., Shishkin, A., Tabach, Y., Mikkelsen, T. S., Satija, R., Ruvkun, G., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.047 · Cited by 626 · cited 1×
“Recent high-throughput sequencing approaches came up with more than 100 types of RNA modifications [7,8].”
BackgroundALKBH1-Mediated tRNA Demethylation Regulates Translation
Liu, F., Clark, W., Luo, G., Wang, X., Fu, Y., Wei, J., Wang, X., Hao, Z., Dai, Q., Zheng, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.038 · Cited by 584
Li, X., Xiong, X., Zhang, M., Wang, K., Chen, Y., Zhou, J., Mao, Y., Lv, J., Yi, D., Chen, X.-W., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.10.019 · Cited by 485
Self-citationGrand Challenge Commentary: RNA epigenetics?
He, C. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.482 · Cited by 440
RMBase v2.0: deciphering the map of RNA modifications from epitranscriptome sequencing data
Xuan, J.-J., Sun, W.-J., Lin, P.-H., Zhou, K.-R., Liu, S., Zheng, L.-L., Qu, L.-H., & Yang, J.-H. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx934 · Cited by 425
Reversal of DNA alkylation damage by two human dioxygenases
Duncan, T., Trewick, S. C., Koivisto, P., Bates, P. A., Lindahl, T., & Sedgwick, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262589799 · Cited by 413
Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs
Chen, Z., Qi, M., Shen, B., Luo, G., Wu, Y., Li, J., Lu, Z., Zheng, Z., Dai, Q., & Wang, H. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1250 · Cited by 357 · cited 1×
“This clinical challenge emphasizes the importance of early detection and/or prediction of GI cancers; however, there are few reports on m1A in GI cancers [17].”
BackgroundSelf-citationAlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells
Ueda, Y., Ooshio, I., Fusamae, Y., Kitae, K., Kawaguchi, M., Jingushi, K., Hase, H., Harada, K., Hirata, K., & Tsujikawa, K. (2017) · Scientific Reports · doi:10.1038/srep42271 · Cited by 305
RNA modifications: what have we learned and where are we headed?
Frye, M., Jaffrey, S. R., Pan, T., Rechavi, G., & Suzuki, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.47 · Cited by 282 · cited 1×
“Recently, there has been an increase in interest in RNA methylation, such as N6-methyladenosine (m6A), 5-methyl cytidine (m5C; also known as 5mC), and m1A [29].”
BackgroundVilardo, E., Nachbagauer, C., Buzet, A., Taschner, A., Holzmann, J., & Rossmanith, W. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks910 · Cited by 273
Identification of YTH Domain-Containing Proteins as the Readers for N 1-Methyladenosine in RNA
Dai, X., Wang, T., Gonzalez, G., & Wang, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01703 · Cited by 256 · cited 3×
“N1-methyladenosine (m1A) is a crucial posttranscriptional modification in RNA which was first documented more than five decades ago [9,10].”
BackgroundChujo, T., & Suzuki, T. (2012) · RNA · doi:10.1261/rna.035600.112 · Cited by 217
Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays
Li, J., Zhao, W., Akbani, R., Liu, W., Ju, Z., Ling, S., Vellano, C. P., Roebuck, P., Yu, Q., Eterovic, A. K., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.005 · Cited by 209
Self-citationThe occurence of 1-methyladenine in ribonucleic acid
Dunn, D. B. (1961) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(61)90668-0 · Cited by 205 · cited 1×
“N1-methyladenosine (m1A) is a crucial posttranscriptional modification in RNA which was first documented more than five decades ago [9,10].”
BackgroundCoordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
Cao, Q., Mani, R.-S., Ateeq, B., Dhanasekaran, S. M., Asangani, I. A., Prensner, J. R., Kim, J. H., Brenner, J. C., Jing, X., Cao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.016 · Cited by 204 · cited 1×
“This is an understudied area in contrast to numerous studies conducted on epigenetic regulations of DNA and histones [5].”
ResultSelf-citationReversible RNA Modification N 1-Methyladenosine (m1A) in mRNA and tRNA
Zhang, C., & Jia, G. (2018) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.03.003 · Cited by 202 · cited 1×
“Previous studies pointed to the presence of m1A in tRNA, rRNA, mRNA, and mitochondrial (mt) transcripts [15].”
BackgroundALKBH1-Mediated tRNA Demethylation Regulates Translation
Liu, F., Clark, W. C., Luo, G., Wang, X., Fu, Y., Wei, J., Wang, X., Hao, Z., Dai, Q., Zheng, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.045 · Cited by 164
DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database
Xiong, Y., Wei, Y., Gu, Y., Zhang, S., Lyu, J., Zhang, B., Chen, C., Zhu, J., Wang, Y., Liu, H., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1123 · Cited by 164
Kaboli, P. J., Rahmat, A. B., Ismail, P., & Ling, K. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.025 · Cited by 157
Self-citationOZANICK, S., KRECIC, A., ANDERSLAND, J., & ANDERSON, J. T. (2005) · RNA · doi:10.1261/rna.5040605 · Cited by 150 · cited 1×
“In mammals, nine members of m1A regulators have been identified catalyzed by writers (“TRMT6,” “TRMT61A,” “TRMT10C”) [38,39], reversed by erasers (“ALKBH1,” “ALKBH3”) [40,41], and specially recognized by readers (“YTHDF1-3,” “YTHDC1”) with YTH domain [10], all of which are associated with RNA metabolism.”
BackgroundVerhaegen, M., Bauer, J. A., Martín de la Vega, C., Wang, G., Wolter, K. G., Brenner, J. C., Nikolovska-Coleska, Z., Bengtson, A., Nair, R., Elder, J. T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1748 · Cited by 140
Metodiev, M. D., Thompson, K., Alston, C. L., Morris, A. A. M., He, L., Assouline, Z., Rio, M., Bahi‐Buisson, N., Pyle, A., Griffin, H. R., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.010 · Cited by 120
Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer
Li, Y., Zheng, D., Wang, F., Xu, Y., Yu, H., & Zhang, H. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5452-2 · Cited by 118 · cited 1×
“It has been previously shown that the overexpression of ALKBH1 is significantly associated with poor prognosis and metastasis in gastric cancer [44].”
BackgroundSelf-citationPCA-1/ALKBH3 Contributes to Pancreatic Cancer by Supporting Apoptotic Resistance and Angiogenesis
Yamato, I., Sho, M., Shimada, K., Hotta, K., Ueda, Y., Yasuda, S., Shigi, N., Konishi, N., Tsujikawa, K., & Nakajima, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0328 · Cited by 116
N1-methyladenosine methylome in messenger RNA and non-coding RNA
Xiong, X., Li, X., & Yi, C. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.06.017 · Cited by 113
Self-citationVishnubalaji, R., Hamam, R., Abdulla, M.-H., Vaali‐Mohammed, M., Kassem, M. S., Alobeed, O., Aldahmash, A. M., & Alajez, N. M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.556 · Cited by 99 · cited 1×
“Several studies have reported that aberrant PPIs were the basis of cancer occurrence and progression [56,57].”
BackgroundEpigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives
Vedeld, H. M., Goel, A., & Lind, G. E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.12.004 · Cited by 92
Kaboli, P. J., Leong, M. P.-Y., Ismail, P., & Ling, K. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.07.005 · Cited by 67 · cited 2×
“Genetic mutations usually cause phenotypic changes, which are closely related to carcinogenesis and aging [34].”
BackgroundSelf-citationVilardo, E., & Rossmanith, W. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv408 · Cited by 66
m 1 A within cytoplasmic mRNAs at single nucleotide resolution: a reconciled transcriptome-wide map
Schwartz, S. (2018) · RNA · doi:10.1261/rna.067348.118 · Cited by 64
Barraud, P., Golinelli‐Pimpaneau, B., Atmanène, C., Cianférani, S., DORSSELAER, A. V., Droogmans, L., Dardel, F., & Tisné, C. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.041 · Cited by 63
Vilardo, E., & Rossmanith, W. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv658 · Cited by 62
Linking signaling pathways to transcriptional programs in breast cancer
Osmanbeyoglu, H. U., Pelossof, R., Bromberg, J., & Leslie, C. S. (2014) · Genome Research · doi:10.1101/gr.173039.114 · Cited by 61 · cited 1×
“Tumor cells often acquired genetic and epigenetic alterations that always contribute to oncogene dysregulation and widespread changes in gene expression [42].”
BackgroundTranslocations in epithelial cancers
Brenner, J. C., & Chinnaiyan, A. M. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.04.005 · Cited by 48
CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell–Relevant Genes
Aznar, M. A., Labiano, S., Díaz‐Lagares, Á., Molina, C., Garasa, S., Azpilikueta, A., Etxeberría, I., Sánchez-Paulete, A. R., Korman, A. J., Esteller, M., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0159 · Cited by 44 · cited 1×
“Promoter of DNA methylation may represent a key epigenetic mechanism in regulating gene expression [51].”
BackgroundLiu, Y., Yasukawa, M., Chen, K., Hu, L., Broaddus, R. R., Ding, L., Mardis, E. R., Spellman, P. T., Levine, D. A., Mills, G. B., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1432 · Cited by 42 · cited 1×
“m1A Regulator Gene Alteration in GI Cancers Somatic mutations are associated with prognosis and chemotherapy sensitivity [36].”
BackgroundKaboli, P. J., Ismail, P., & Ling, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193941 · Cited by 39
Self-citationScreening in GI Cancers: The Role of Genetics
Stoffel, E. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.6764 · Cited by 32 · cited 1×
“Genetic mutations have been document to play an important role in GI cancer formation [26,27].”
BackgroundThe potential for tumor suppressor gene therapy in head and neck cancer.
Birkeland, A. C., Ludwig, M., Spector, M. E., & Brenner, J. C. (2016) · PubMed · Cited by 30
Cited by
Wang, Y., Wang, J., Li, X., Xiong, X., Wang, J., Zhou, Z., Zhu, X., Gu, Y., Dominissini, D., He, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26718-6 · Cited by 265
Self-citationShi, H., Chai, P., Jia, R., & Fan, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01194-6 · Cited by 249
Metadata
- Authors
- Zhao, Y., Zhao, Q., Kaboli, P. J., Shen, J., Li, M., Wu, X., Yin, J., Zhang, H., Wu, Y., Lin, L., Zhang, L., Wan, L., Wen, Q., Li, X., Cho, C. H., Yi, T., Li, J., & Xiao, Z.
- Venue
- Translational Oncology
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 12
- Issue
- 10
- Pages
- 1323-1333
- ISSN
- 1936-5233 (ISSN-L)
- OpenAlex
- W2963513084
- Cited by
- 187
- References
- 62
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.